Inspire Medical Systems (NYSE:INSP) Trading Down 6% – Here’s What Happened

Inspire Medical Systems, Inc. (NYSE:INSP)’s share price was down 6% during trading on Wednesday . The stock traded as low as $47.36 and last traded at $47.0710. Approximately 55,624 shares traded hands during trading, a decline of 95% from the average session volume of 1,203,093 shares. The stock had previously closed at $50.08.

Analysts Set New Price Targets

Several analysts have weighed in on INSP shares. Wells Fargo & Company lowered their price target on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 5th. Truist Financial cut their price objective on Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a report on Tuesday, May 5th. Evercore cut shares of Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price objective on the stock. in a research report on Tuesday, June 23rd. Robert W. Baird lowered their target price on shares of Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, fourteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $81.05.

Inspire Medical Systems Price Performance

The company has a 50 day simple moving average of $44.12 and a 200-day simple moving average of $60.45. The stock has a market cap of $1.49 billion, a P/E ratio of 11.48, a price-to-earnings-growth ratio of 4.99 and a beta of 0.71.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. The firm had revenue of $204.58 million for the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The company’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, research analysts expect that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current year.

Institutional Investors Weigh In On Inspire Medical Systems

A number of hedge funds have recently made changes to their positions in INSP. Daiwa Securities Group Inc. grew its holdings in shares of Inspire Medical Systems by 38.7% during the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after purchasing an additional 130 shares during the last quarter. State of Wyoming lifted its stake in Inspire Medical Systems by 31.5% in the fourth quarter. State of Wyoming now owns 731 shares of the company’s stock worth $67,000 after purchasing an additional 175 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in Inspire Medical Systems by 84.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after purchasing an additional 205 shares during the last quarter. Apollon Wealth Management LLC boosted its position in Inspire Medical Systems by 5.6% during the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after buying an additional 212 shares during the period. Finally, Blair William & Co. IL grew its stake in shares of Inspire Medical Systems by 5.1% during the third quarter. Blair William & Co. IL now owns 4,865 shares of the company’s stock valued at $361,000 after buying an additional 234 shares during the last quarter. 94.91% of the stock is currently owned by institutional investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.